Retinitis Pigmentosa

14 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Retinitis Pigmentosa
Treatment and conditionWhere it standsTrials
1.5 x 10^6 UC-MSC + CM for retinitis pigmentosaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
5 x 10^6 UC-MSC + CM for retinitis pigmentosaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AAV2-hRPE65v2,voretigene neparvovec-rzyl for retinitis pigmentosaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BS01 for retinitis pigmentosaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE) for retinitis pigmentosaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU400 High Dose for retinitis pigmentosaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU400 High Dose + OCU400 Med Dose for retinitis pigmentosaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU400 Low Dose for retinitis pigmentosaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU400 Med Dose for retinitis pigmentosaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
OCU400 Second Eye Dosing for retinitis pigmentosaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
PRIMA Products for retinitis pigmentosaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Puliretgene Parvec for retinitis pigmentosaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
rAAV2.REP1 for retinitis pigmentosaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
RTx-015 for retinitis pigmentosaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1